Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cancerfacts.com Inc.

This article was originally published in Start Up

Executive Summary

Cancerfacts.com has created an interactive website for cancer patients which will, among other things, analyze a user's medical profile against a database of peer-reviewed clinical studies. The result is a report setting forth treatment options, given the patient's condition, as well as information on side effects and potential treatment outcomes. Although there will be a Cancerfacts.com site, the company expects to make most of its money by selling its technology platform to various health care organizations for use on their websites.

You may also be interested in...



A New Breed In E-Health

For the last few years, industry observers have tended to group e-health into three distinct categories: content, connectivity and commerce (B2C or B2B). But today's e-health company is a unique crossbreed blending health-related content, commerce and services for consumers.

AureoGen Biosciences Inc.

Formed by Kalamazoo-based Pharmacia alumni, AureoGen Biosciences Inc. is genetically engineering cyclic peptides to create second-generation, resistance-proof anti-infective and anti-fungal therapeutics.

Pain Therapeutics

Pain seems as close to a sure bet as the pharmaceutical industry has to offer. Forecasts call for the worldwide analgesic market, already $38 billion in 2002, to grow at a 20% annual clip, nearly doubling to $75 billion by the year 2010. For new drug developers, pain also has the advantage of offering clearly definable endpoints-less pain-and a relatively short duration for clinical trials. No surprise then that more than 200 companies have a hand in developing or marketing pain therapeutics. Among them, the three young companies profiled here-AlgoRx Pharmaceuticals Inc., Algos Therapeutics Inc., and TheraQuest Biosciences LLC.

Topics

Related Companies

UsernamePublicRestriction

Register

SC090191

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel